Israel Cleantech Ventures

Managing Partners Eli Nir and Isaac Hillel lead investment decisions. Both have been with the firm since its 2005 founding and have backgrounds in Israeli technology and venture capital (public record).

ICV sources deals primarily through its long-standing network within Israeli research universities, the Office of the Chief Scientist (now Israel Innovation Authority), and corporate partners in energy and industrials. The firm's two-decade focus on cleantech in Israel gives it concentrated local relationships (public record).

ICV invests directly into startups, typically leading or co-leading seed and Series A rounds. It does not operate a fund-of-funds model and does not make commitments to other venture funds (public record).

The firm targets seed through Series B rounds, with a focus on Series A. It looks for capital-efficient companies that require $2M–$10M total funding to reach commercial scale (public record).

ICV avoids software-only plays and digital health, as well as purely financial technology. The firm's mandate is limited to physical-science-based cleantech including energy, water, agriculture, and materials (public record).

ICV frequently co-invests with other Israeli and international venture firms. Known co-investors have included Terra Venture Partners, 83North, and Khosla Ventures on specific deals (public record).